Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

20 Oct 2006 07:00

Charlemagne Capital Limited20 October 2006 20 October 2006 Purchase of own shares for cancellation Charlemagne Capital Limited ("Charlemagne", the "Company") announces that onThursday 19 October 2006 it purchased and cancelled 500,000 Ordinary Shares ofUS$0.01 each in the Company through UBS Limited at a price, before expenses, of61 pence each. As a result of these purchases and cancellations, Charlemagne will have294,461,772 Ordinary Shares of US$0.01 each in issue. At its Annual General Meeting held on 22 May 2006, Charlemagne was authorised byits shareholders to purchase up 29,771,177 of its ordinary shares (representing10% of its issued capital at that time) subject to certain conditions asoutlined in the resolution. Since that date a total of 3,250,000 ordinary shareshave been purchased and cancelled. Enquiries Charlemagne Capital 01624 640200David McMahon, Company Secretary Smithfield Consultants 020 7360 4900John KielyGeorge Hudson Notes to editors Charlemagne Capital is a specialist emerging markets equity investmentmanagement group. Charlemagne Capital Limited was admitted to the AIM market ofthe London Stock Exchange on 4 April 2006. Charlemagne's product range comprises mutual funds, hedge funds andinstitutional and specialist fund products primarily covering GEMs, EasternEurope, Latin America and Asia. Charlemagne Capital employs a range ofinvestment strategies including: long only, long/short, structured products andprivate equity. Charlemagne Capital's funds aim to exploit the inefficiencies inthe market via a strict bottom up approach and focused stock selection. Through the strong long-term investment performance track record of itsprincipal funds, Charlemagne Capital has established itself as a market leaderin emerging markets investment management. Its performance has been recognisedthrough numerous awards and top rankings for its funds, including the 2005Standard and Poor's 5-year best performing fund award in Austria, the 2006 SwissLipper Leaders 5-year award winner for Emerging Markets Europe and an AAA-ratingby Standard & Poor's for its Magna Eastern European Fund (a sub-fund of MagnaUmbrella Fund Plc). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Sep 20217:00 amRNSInterim Results
11th Aug 202112:33 pmRNSResult of AGM
4th Aug 20217:00 amRNSProposed reverse takeover of Smarttech247
16th Jul 20211:00 pmRNSRevised Notice of AGM & Adjournment of AGM
30th Jun 20215:51 pmRNSFinal Results for the year ended 31 December 2020
6th Apr 20217:30 amRNSSuspension - Conduity Capital PLC
1st Apr 20213:45 pmRNSDirector/PDMR Shareholding
31st Mar 20214:28 pmRNSTR-1: Notification of major holdings
30th Mar 202111:38 amRNSTR-1: Notification of major holdings
29th Mar 20214:41 pmRNSSecond Price Monitoring Extn
29th Mar 20214:35 pmRNSPrice Monitoring Extension
29th Mar 20212:05 pmRNSTR-1: Notification of major holdings
29th Mar 20211:48 pmRNSDirector/PDMR Shareholding
25th Mar 20212:00 pmRNSTR-1: Notification of major holdings
25th Mar 202112:47 pmRNSTR-1: Notification of major holdings
24th Mar 20214:41 pmRNSSecond Price Monitoring Extn
24th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 202111:05 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20219:25 amRNSIssue of Equity and Total Voting Rights
24th Mar 20219:05 amRNSSecond Price Monitoring Extn
24th Mar 20219:00 amRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSAIM Rule 15 and Corporate Update
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
19th Mar 202111:00 amRNSPrice Monitoring Extension
19th Mar 20219:00 amRNSPrice Monitoring Extension
19th Mar 20218:42 amRNSTR-1: Notification of major holdings
16th Mar 202110:19 amRNSTR-1: Notification of major holdings
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
5th Mar 20214:40 pmRNSSecond Price Monitoring Extn
5th Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20218:47 amRNSTR-1: Notification of major holdings
26th Feb 202112:02 pmRNSIssue of Equity and Total Voting Rights
26th Feb 20219:42 amRNSTR-1: Notification of major holdings
22nd Feb 202112:07 pmRNSIssue of Equity and Total Voting Rights
16th Feb 202110:50 amRNSTR-1: Notification of major holdings
8th Feb 20218:38 amRNSIssue of Equity and Total Voting Rights
3rd Feb 202112:51 pmRNSIssue of Equity and Total Voting Rights
3rd Feb 20217:42 amRNSTR-1: Notification of major holdings
1st Feb 202111:04 amRNSIssue of Equity and Total Voting Rights
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:35 pmRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:00 pmRNSPrice Monitoring Extension
27th Jan 20219:53 amRNSIssue of Equity and Total Voting Rights
26th Jan 20211:53 pmRNSTR-1: Notification of major holdings
25th Jan 20217:50 amRNSTR-1: Notification of major holdings
20th Jan 20213:30 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.